Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings

Background and aims Opioid agonist treatment is effective but resource intensive to administer safely in custodial settings, leading to significant under‐treatment of opioid dependence in these settings world‐wide. This study assessed the safety of subcutaneous slow‐release depot buprenorphine in cu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Addiction (Abingdon, England) England), 2022-02, Vol.117 (2), p.382-391
Hauptverfasser:	Dunlop, Adrian J., White, Bethany, Roberts, Jillian, Cretikos, Michelle, Attalla, Dena, Ling, Rod, Searles, Andrew, Mackson, Judith, Doyle, Michael F., McEntyre, Elizabeth, Attia, John, Oldmeadow, Christopher, Howard, Mark V., Murrell, Terry, Haber, Paul Steven, Lintzeris, Nicholas
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Agonists Analgesics, Opioid - therapeutic use Buprenorphine Buprenorphine - therapeutic use CAM2038 Classification Critical incidents depot Drug addiction Drug dependence Female Humans Male Medical diagnosis Methadone Methadone - therapeutic use Narcotic Antagonists - therapeutic use Narcotics Opiate Substitution Treatment opioid use disorder Opioid-Related Disorders - drug therapy Opioids Patients Prisoners prisons Recruitment Research Report Research Reports safety slow‐release subcutaneous Substance abuse treatment Substance use Substance use disorder
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!